Prolanta and all the patents was the reason I invested here. A lot of potential if the 2nd cohort results were positive for phase 1. Unfortunately the 2 people tested had slight reactions to the injections.
Prolanta has to be reformulated at this point for a possible different delivery method. The only hope Oncolix has would be a huge investor willing to invest a ton of cash.
Who knows maybe GHS would fund this, especially being the largest shareholder.